TipRanks
Design Therapeutics (DSGN)
NASDAQ:DSGN
US Market
DSGN
Design Therapeutics
RESEARCH TOOLSreports
Want to see DSGN full AI Analyst Report?

Design Therapeutics (DSGN) Balance Sheet

108 Followers

Design Therapeutics Balance Sheet

Design Therapeutics's total assets for Q2 2026 were $215.13M, a decrease of -6.65% from the previous quarter. DSGN total liabilities were $13.27M for the fiscal quarter, a 7.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 226.20M$ 252.09M$ 289.64M$ 341.14M$ 390.56M
Total Liabilities
$ 13.70M$ 10.00M$ 11.96M$ 13.83M$ 8.43M
Total Equity Gross Minority
$ 212.50M$ 242.10M$ 277.69M$ 327.31M$ 382.13M
Other Metrics
Currency in USD

Design Therapeutics Debt to Assets